13-32355172-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000059.4(BRCA2):​c.7319A>G​(p.His2440Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00166 in 1,612,128 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H2440Y) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0090 ( 22 hom., cov: 32)
Exomes 𝑓: 0.00089 ( 13 hom. )

Consequence

BRCA2
NM_000059.4 missense

Scores

14

Clinical Significance

Benign reviewed by expert panel U:1B:35O:1

Conservation

PhyloP100: -1.26

Publications

33 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003717512).
BP6
Variant 13-32355172-A-G is Benign according to our data. Variant chr13-32355172-A-G is described in ClinVar as Benign. ClinVar VariationId is 41562.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00902 (1371/152076) while in subpopulation AFR AF = 0.0314 (1304/41520). AF 95% confidence interval is 0.03. There are 22 homozygotes in GnomAd4. There are 656 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.7319A>Gp.His2440Arg
missense
Exon 14 of 27NP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.7319A>Gp.His2440Arg
missense
Exon 14 of 27NP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.7319A>Gp.His2440Arg
missense
Exon 14 of 27NP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.7319A>Gp.His2440Arg
missense
Exon 14 of 27ENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.7319A>Gp.His2440Arg
missense
Exon 14 of 27ENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.6950A>Gp.His2317Arg
missense
Exon 14 of 27ENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
AF:
0.00902
AC:
1371
AN:
151950
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0315
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00309
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00716
GnomAD2 exomes
AF:
0.00236
AC:
594
AN:
251188
AF XY:
0.00170
show subpopulations
Gnomad AFR exome
AF:
0.0331
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000893
AC:
1304
AN:
1460052
Hom.:
13
Cov.:
35
AF XY:
0.000765
AC XY:
556
AN XY:
726408
show subpopulations
African (AFR)
AF:
0.0312
AC:
1043
AN:
33410
American (AMR)
AF:
0.00154
AC:
69
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26086
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39486
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86220
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53158
Middle Eastern (MID)
AF:
0.000869
AC:
5
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000432
AC:
48
AN:
1110978
Other (OTH)
AF:
0.00211
AC:
127
AN:
60284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
74
149
223
298
372
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00902
AC:
1371
AN:
152076
Hom.:
22
Cov.:
32
AF XY:
0.00882
AC XY:
656
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.0314
AC:
1304
AN:
41520
American (AMR)
AF:
0.00308
AC:
47
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4782
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
67982
Other (OTH)
AF:
0.00709
AC:
15
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
72
143
215
286
358
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00322
Hom.:
14
Bravo
AF:
0.0103
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0311
AC:
137
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00306
AC:
371
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
8
Breast-ovarian cancer, familial, susceptibility to, 2 (9)
-
-
7
not specified (8)
-
-
5
Hereditary breast ovarian cancer syndrome (5)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
4
not provided (4)
-
-
2
Familial cancer of breast (2)
-
-
1
BRCA2-related cancer predisposition (1)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Fanconi anemia complementation group D1 (1)
-
-
1
Malignant tumor of breast (1)
-
-
1
Medulloblastoma;C0346153:Familial cancer of breast;C0376358:Prostate cancer;C1838457:Fanconi anemia complementation group D1;C2675520:Breast-ovarian cancer, familial, susceptibility to, 2;C2751641:Glioma susceptibility 3;C3150546:Pancreatic cancer, susceptibility to, 2;CN033288:Wilms tumor 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.050
DANN
Benign
0.68
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.082
N
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-0.90
T
PhyloP100
-1.3
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.15
Sift
Benign
0.30
T
Sift4G
Benign
0.49
T
Vest4
0.24
MVP
0.74
MPC
0.022
ClinPred
0.0078
T
GERP RS
-7.8
gMVP
0.16
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4986860; hg19: chr13-32929309; API